State bills: Missouri · Health
What's moving in state legislatures -- introductions, committee action, floor votes and sponsors.
Filter bills
-
SB 1222 — Missouri
Modifies provisions relating to intervention in actions involving abortion
SB 1222 - This act establishes that pro-life individuals and organizations, as defined in the act, may intervene in actions in which a provision of the Missouri Constitution, statute, or rule involves the regulation of abortion or where the rights of an unborn child is at issue. This act is substantially similar to a provision in SB 794 (2025). SARAH HASKINS
-
SB 1114 — Missouri
Requires health benefit plans to cover prostheses for hair loss due to cancer treatment
SB 1114 - This act requires health benefit plans to provide coverage for prostheses and scalp hair prostheses worn for hair loss suffered as a result of cancer treatment. The coverage is subject to benefit limits and restrictions on out-of-pocket costs, as specified in the act. This act is substantially similar to SB 345 (2025), SB 1046 (2024), and HB 2393 (2024). TAYLOR MIDDLETON
-
SB 1155 — Missouri
Establishes the "Missouri Respond, Innovate, Succeed and Empower (RISE) Act" relating to accommodations for students with disabilities at public institutions of higher education
SB 1155 - This act creates the "Missouri Respond, Innovate, Succeed, and Empower (RISE) Act". Under this act, a public institution of higher education shall adopt a policy that specifies the types of documentation the institution shall accept to determine a student's eligibility for disability accommodations. The act lists the types of documentation that shall be accepted, including documentation related to Individualized Education Programs (IEPs) and 504 plans developed under federal law, provided that any IEP or 504 plan documentation shall represent an ongoing need for disability accommodations that has not ended. An institution may set simpler criteria than those specified in the act to determine whether a student qualifies as an individual with a disability. The policy shall clearly outline the process for determining eligibility for disability accommodations. This information shall be shared with students, parents, and faculty in accessible formats and made available on the institution's website. OLIVIA SHANNON
-
SB 1113 — Missouri
Enacts provisions relating to insurance coverage of genetic screenings for cancer risk
SB 1113 - This act requires health benefit plans to provide coverage for genetic testing and genetic counseling, as defined in the act, of individuals who are at increased risk of potentially harmful mutations to their genes due to a personal or family history of cancer. The act prohibits insurers from using these tests and counseling in underwriting decisions such as calculating premiums or determining coverage, and prohibits insurers from imposing cost-sharing with regard to the required coverage. This act is identical to HB 1879 (2026), substantially similar to SB 824 (2025) and HB 1080 (2025), and similar to SB 406 (2025), SB 1047 (2024), and HB 2394 (2024). TAYLOR MIDDLETON
-
SB 1143 — Missouri
Modifies provisions relating to certificates of need for long-term care facilities
SB 1143 - Under current law, a certificate of need is not required for transfer of ownership of an existing and operational health facility in its entirety. This act requires a certificate of need for any such transfer of an assisted living, intermediate care, residential, or skilled nursing facility. This act is identical to a provision of SB 733 (2025). SARAH HASKINS
-
SB 1147 — Missouri
Enacts provisions relating to insurance coverage for mental health treatments
SB 1147 - This act provides that health benefit plans shall not impose greater cost-sharing requirements for certain treatment of behavioral or mental health conditions if a hospital is out-of-network, as provided in the act, and that the health carrier shall reimburse the out-of-network hospital for the treatment at the same rate as the hospital would be reimbursed by MO HealthNet or Medicare, whichever is greater. The act also provides that maintaining inadequate behavioral and mental health provider networks, as described in the act, shall be an unlawful practice enforceable under the Missouri Merchandising Practices Act. This act is substantially similar to SB 567 (2025) and similar to SB 550 (2025) and HB 1071 (2025). TAYLOR MIDDLETON
-
SB 1134 — Missouri
Establishes provisions requiring health care facilities to display certain signs
SB 1134 - Under this act, each health care facility shall prominently display a printed sign, in all capital letters, warning that assaulting a health care professional is a serious crime which may be punishable as a class A misdemeanor. This act is identical to SB 791 (2025) and substantially similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), SS/SCS/SB 841 (2026), HCS/HB 1213 (2025), HCS/SB 1019 (2026), SB 1775 (2026), and HCS/SB 943 (2025). SARAH HASKINS
-
SB 1156 — Missouri
Enacts provisions relating to insurance coverage for prescription insulin drugs
SB 1156 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of thirty dollars per thirty-day supply of a prescription insulin drug. This act also requires health benefit plan enrollees' cost-sharing for prescription insulin drugs to be calculated at the point of sale, and based on a price that is reduced by an amount equal to at least 100% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. Nothing in the act shall prohibit copayments not based on the price of a drug, provided that the copayment does not exceed the reduced price of the drug. The act shall not require a health carrier or its agents to reveal information regarding the actual amount of rebates a carrier receives on a product, manufacturer, or pharmacy-specific basis. The act also provides confidentiality protections, as specified in the act, which the carriers shall follow as well as impose on any third party that performs health care or administrative services on behalf of the carrier and may receive or have access to rebate information. This act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2027. This act is identical to HB 3117 (2026), SB 175 (2025), similar to provisions in HCS/HB 1195 (2025) and HB 186 (2025), identical to HB 2262 (2024), substantially similar to SB 1182 (2024), identical to SB 283 (2023), similar to SB 815 (2022), and contains provisions similar to SB 814 (2022). TAYLOR MIDDLETON
-
SB 1141 — Missouri
Creates provisions relating to the right to refuse to participate in certain medical treatment
SB 1141 - Under this act, no health care institution, health care professional, or other person shall be required to perform, assist, or participate in medical procedures, treatments, counseling, prescriptions, or surgeries related to sex reassignment or gender identity transitioning if such procedures, treatments, counseling, prescriptions, or surgeries are contrary to the established policy of, or the moral, ethical, or religious beliefs of, such institution or professional or other person. No person shall be denied or discriminated against in the receipt of any public benefit, assistance, or privilege or denied or discriminated against in the public or private employment on the grounds of refusal to perform, assist, or participate in sex reassignment or gender identity transitioning medical procedures, treatments, counseling, prescriptions, or surgeries, as described in the act. No cause of action shall accrue against an institution, professional, or other person on account of the refusal to perform, assist, or participate in such described activities. An institution, professional, or other aggrieved person may bring a civil action for a violation of the rights set forth in this act. This act is similar to HB 1519 (2024). SARAH HASKINS
-
SB 1047 — Missouri
Enacts provisions relating to insurance coverage for cancer treatment
SB 1047 - This act enacts "The Missouri Advanced Stage Cancer Cost Burden Cap". The act provides that no health benefit plan shall impose cost-sharing for treatment of advanced stage cancer, as defined in the act, other than the deductible otherwise applicable under the plan. This act is identical to SB 308 (2025) and SB 1102 (2024). TAYLOR MIDDLETON
-
SB 1026 — Missouri
Creates provisions regulating intoxicating cannabinoids
SB 1026 - Under this act, any person or entity selling in this state any intoxicating cannabinoid shall not be prohibited from doing so by any law regulating or restricting the sale of cannabis; provided that such products are: (1) sold only to adults 21 years of age or older upon age verification; (2) compliant with testing and safety regulations; (3) compliant with packaging and labeling regulations to protect minors; and (4) compliant with other regulations promulgated by the Department of Health and Senior Services. Any person or entity selling intoxicating cannabinoids shall annually register with the Department prior to the sale of such products, as described in the act. This act is identical to SB 641 (2025) and similar to provisions of the truly agreed to and finally passed SS/HCS/HB 2641 (2026), SCS/SB 54 (2025), and SB 518 (2025). SARAH HASKINS
-
SB 1037 — Missouri
Modifies provisions relating to public health services
SB 1037 - This act authorizes the Department of Health and Senior Services to contract with a designated Missouri affiliate of the National Network of Public Health Institutes, or a similar or successor entity, in order to assist in carrying out its duties to promote the health and well-being of Missouri residents. Such contracts may include efforts to assist in the delivery of health services throughout the state and the administration of grant funds and related programs. The Department and the designated affiliate shall provide a report to the General Assembly as specified in the act. This act is identical to SB 549 (2025) and substantially similar to a provision in SS/SCS/SB 841 (2026) and SB 1525 (2026). SARAH HASKINS
-
SB 842 — Missouri
Establishes "Cindi's Law" requiring certain diagnostic tests for uterine cancer
SB 842 - This act establishes "Cindi's Law", requiring all tests of abnormal cytological or histological endometrial samples from the uterine lining to include a test to detect the presence and pattern of abnormalities in the p53 protein for the purposes of diagnosis and treatment of uterine cancer. SARAH HASKINS
-
SB 840 — Missouri
Creates provisions relating to cost-sharing under health benefit plans
SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON
-
SB 1010 — Missouri
Modifies provisions relating to child protection, including child abuse and endangering a child
SB 1010 - Under this act, a child shall not be considered abused or neglected for the sole reason that the child's parent, guardian, or other person responsible for the child's care, custody, and control refuses to affirm or otherwise recognize the child's sexual orientation or gender identity if that gender identity differs from the child's biological sex. Additionally, the Children's Division shall not investigate or conduct a family assessment for the sole reason that the child's parent, guardian, or other person responsible for the child's care, custody, and control refuses to affirm or otherwise recognize the child's sexual orientation or gender identity if that gender identity differs from the child's biological sex. Finally, the offense of endangering the welfare of a child in the first and second degrees shall not include a person's refusal to affirm or otherwise recognize the child's sexual orientation or gender identity if that gender identity differs from the child's biological sex and shall not include if the person refuses to assist or give consent to a child's gender transition. This act is identical to SB 704 (2025). SARAH HASKINS
-
SB 950 — Missouri
Modifies provisions relating to taxation
SB 950 - This act modifies several provisions relating to taxation. INDIVIDUAL INCOME TAX For all tax years beginning on or after January 1, 2027, this act reduces the top rate of tax by 0.17%. Such reduction in the top rate of tax shall only occur if one or more institutions is subject to the tax on the endowments of higher education institutions imposed under this act. (Section 143.011) HIGHER EDUCATION ENDOWMENT TAX For all tax years beginning on or after January 1, 2027, this act imposes a tax on the endowments of qualifying institutions of higher education at a rate of 1.9% of the aggregate fair market value of the assets of such endowments. The tax shall apply to the endowments, as defined in the act, of higher education institutions that 1) are affiliated with, or provide medical faculty to, any abortion facility, 2) offer specific medical residencies or fellowships that offer training in performing or inducing abortions, or 3) support in any manner any abortion facility where abortions are performed or induced when not necessary to save the life of the mother. Any institution that becomes a qualifying institution of higher education on or after January 1, 2027, shall remain subject to the tax imposed by the act regardless of whether such institution no longer meets the definition of qualifying institution of higher education as defined in the act. All revenues generated by the endowment tax shall be deposited in the General Revenue Fund. (Section 146.200) This act is identical to HB 3444 (2026), SB 27 (2025), SB 1143 (2024), HB 2114 (2024), SB 290 (2023), SB 892 (2022), HB 1874 (2022), SB 451 (2021), and HB 302 (2021), and is substantially similar to HB 1332 (2023), SCS/SB 574 (2020), and SCS/SB 188 (2019). JOSH NORBERG
-
SB 900 — Missouri
Modifies provisions relating to assisted reproductive technology
SB 900 - This act modifies provisions relating to assisted reproductive technology. DEFINITION OF UNBORN CHILD (Section 1.205) This act modifies the definition of "unborn child" or "unborn children" to exclude human embryos created through assisted reproductive technology, including in vitro fertilization, prior to successful implantation in the uterus. These provisions are identical to SB 605 (2025) and HB 3244 (2026), and substantially similar to SB 1486 (2024), and similar to HB 2845 (2024). DIAGNOSIS AND TREATMENT OF INFERTILITY (Section 376.1211) This act requires certain health benefit plans providing pregnancy-related benefits to include coverage for the diagnosis and treatment of infertility, as described in the act. These provisions contain an exception for health benefit plans issued by or to religious institutions or organizations. These provisions are identical to HB 2724 (2026) and HB 3244 (2026), and substantially similar to HB 487 (2025). TAYLOR MIDDLETON
-
SB 951 — Missouri
Modifies provisions relating to the protection of unborn children
SB 951 - This act establishes the "Equal Protection Act". Under this act, the intent of the General Assembly is to acknowledge the sanctity of innocent human life, which should be protected from the beginning of biological development to natural death. This act also provides that any person accused of committing any criminal offense against a person under the laws of this state where the victim is an unborn child shall be prosecuted in a venue as provided in the act. The affirmative defense of duress for the offense of murder shall be available where the victim is an unborn child and the defendant is the child's mother. This act also provides it shall be a justifiable defense if a medical procedure is performed by a licensed physician on a pregnant female to avert the death of the female which the results in the accidental or unintentional death of the unborn child and all reasonable alternatives to save the life of the unborn child were unavailable or were unsuccessful. Finally, this act adds the definition of person in the criminal code to include a human being, including an unborn child at every stage of development from the moment of fertilization until birth. This act contains a referendum clause. This act is identical to SB 619 (2025), and to provisions in SB 775 (2024) and SB 356 (2023), and is substantially similar to HB 1682 (2026), HB 1417 (2026), and HB 1072 (2025). TRISTAN BENSON, JR.
-
SB 964 — Missouri
Modifies provisions relating to community paramedics
SB 964 - This act modifies provisions relating to certification of community paramedics and the provision of community paramedic services. Community paramedic services shall mean those services provided by an entity that employs licensed paramedics certified by the Department of Health and Senior Services as community paramedics for services that are provided in a nonemergent setting, consistent with the education and training of a community paramedic and the supervisory standard approved by the medical director, and documented in the entity's patient care plans or protocols. Any ambulance service that seeks to provide community paramedic services outside of its service area shall have a memorandum of understanding (MOU) with the ambulance service of that area if that ambulance service is already providing those services or shall notify the ambulance services of that area if that ambulance service is not providing community paramedic services. Emergency medical response agencies (EMRAs) may provide community paramedic services in a ground ambulance service's service area. If the ground ambulance service is already providing those services, then the EMRA and ground ambulance service may enter into a MOU for the coordination of services. If the ground ambulance service provides those services after the EMRA begins to provide them, then the ground ambulance service and EMRA shall enter into a MOU for the coordination of services. The Department shall establish regulations for the purpose of recognizing community paramedic services entities that have met the standards necessary to provide such services. The Department shall endorse such entities to provide community paramedic services for a period of 5 years. These provisions are similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), SS/SCS/SB 841 (2026), the perfected SS/SB 975 (2026), SCS/HCS/HB 943 (2025) and SCS/SB 317 (2025), SB 548 (2025), SB 206 (2025), and SCS/SB 1382 (2024). SARAH HASKINS
-
SB 929 — Missouri
Enacts provisions relating to insurance coverage of self-administered hormonal contraceptives
SB 929 - Under this act, current law requiring certain health benefit plans to provide coverage for contraceptives lasting up to 90 days, or 180 days for generic self-administered hormonal contraceptives, shall no longer be in effect after December 31, 2026. Instead, certain health benefit plans issued or renewed on or after January 1, 2027, shall be required to cover a supply of self-administered hormonal contraceptives, including brand-name and generic contraceptives, intended to last up to one year. This act is substantially similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed CCS/SS/HCS/HB 2596 (2026), and HB 2370 (2026), and similar to a provision in SCS/SB 178 (2025), HCS/SS/SB 7 (2025), HCS/SB 94 (2025), the perfected HCS/HB 2413 (2024), SB 821 (2024), and SB 1321 (2024). TAYLOR MIDDLETON
-
SB 934 — Missouri
Modifies provisions relating to amending birth certificates
SB 934 - Under current law, a birth certificate may be amended by court order to reflect a surgical sex change. This act prohibits amending a birth certificate when the sex of an individual has been changed by non-surgical means. Additionally, no birth certificate shall be amended if the sex of the individual was changed for reasons other than a medically-verifiable disorder of sex development or to correct a typographic error. This act is substantially similar to SB 100 (2025) and SB 14 (2023). SARAH HASKINS
-
SB 940 — Missouri
Modifies provisions relating to peer review committees
SB 940 - Under this act, any emergency medical services provider licensed under certain provisions of state law shall be considered a health care professional for purposes of liability and disclosure of materials produced by a peer review committee. Any quality improvement or quality assurance activity required by such licensed individuals shall be considered an activity of a peer review committee. Additionally, this act modifies the definition of a "health care professional" in the context of peer review committees and associated immunities from civil liabilities by adding physician assistants. This act is identical to SB 107 (2025) and SCS/SB 1248 (2024). SARAH HASKINS
-
SB 1014 — Missouri
Modifies the "Jason Flatt/Avery Reine Cantor Act" and repeals and modifies provisions relating to mental health efforts in public schools
SB 1014 - Beginning in the 2027-28 school year and continuing in subsequent school years, this act modifies the "Jason Flatt/Avery Reine Cantor Act" by adding a requirement for school districts to provide at least two hours of suicide prevention training to all licensed educators. For the 2028-29 school year and all subsequent school years, such training shall include risk and protective factors, warning signs, response procedures, and postvention support, as the term "postvention" is defined in the act. The Department of Elementary and Secondary Education (DESE) shall include such information in its guidelines for training or professional development in youth suicide awareness and prevention. The act repeals provisions requiring public schools and charter schools to print certain contact information on identification cards for pupils in grades 7-12. By July 1, 2027, pupil identification cards shall include only the three-digit dialing code for the Suicide and Crisis Lifeline, 988. Any unissued cards that include additional contact information shall continue to be issued until the supply of cards is depleted. For the 2028-29 school year and all subsequent school years, each school district shall update its policy on youth suicide awareness and prevention training for school district employees to include risk and protective factors, warning signs, response procedures, and postvention support. The corresponding model policy currently developed by DESE shall be updated accordingly. Finally, beginning in the 2027-28 school year and in each subsequent school year, the act requires each pupil in a public school to receive mental health awareness training at any time in grades 5-8. Such instruction shall be included in the school district's existing health or physical education curriculum and shall be based on a program established by DESE. This act is similar to SB 695 (2025) and provisions in HB 244 (2025) and HCS/HB 2471 (2024). OLIVIA SHANNON
-
SB 930 — Missouri
Creates provisions relating to anesthesia services
SB 930 - Under this act, no health carrier or health benefit plan shall establish, implement, or enforce any policy that imposes a time limit for the payment of anesthesia services provided during a medical or surgical procedure, as described in the act. This provision is identical to provisions in HCS/SB 94 (2025), HCS/HBs 1126 & 932 (2025), and SCS/HCS/HB 94 (2025), and similar to provisions contained in SCS/SB 841 (2026), HB 2570 (2026), the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), HCS/HBs 1945 & 2570, and HB 1944 (2026). TAYLOR MIDDLETON
-
SB 846 — Missouri
Enacts provisions relating to insurance coverage of health care services
SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON
-
SB 924 — Missouri
Establishes the "Compassionate Assistance for Rape Emergencies (CARE) Act"
SB 924 - This act establishes the "Compassionate Assistance for Rape Emergencies (CARE) Act". Under this act, it shall be the standard of care for any hospital or health care facility that provides emergency care to sexual assault victims to inform each victim of the option to be provided emergency contraception at the hospital or health care facility, provide such emergency contraception to each victim who requests it, and provide sexually transmitted infection screening and treatment to the victim. This act is identical to SB 628 (2025) and substantially similar to HB 2121 (2024). SARAH HASKINS
-
SB 884 — Missouri
Provides that the practice of optometry shall include the use of injectable agents and surgical procedures for certain purposes
SB 884 - Currently, the practice of optometry does not include the provision of surgical procedures, including the use of lasers, and does not include the use of injectable agents. Under this act, the practice of optometry shall include the use of injectable agents for the purpose of treatment of the eye and adnexa and shall include surgical procedures, except as otherwise specified and limited by the Board of Optometry. This act is identical to SB 219 (2025) and HB 929 (2025) and is similar to a provision in HB 2897 (2026), SB 956 (2024), and HB 1963 (2024). KATIE O'BRIEN